These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 23748941

  • 1. [Relationship between psychopathological comorbidity and outcomes variables in-treatment cocaine dependent subject in therapeutic community].
    Vergara-Moragues E, González-Saiz F, Lozano-Rojas O, Fernández Calderón F, Verdejo García A, Betanzos Espinosa P, Bilbao Acedos I, Pérez García M.
    Adicciones; 2013; 25(2):128-36. PubMed ID: 23748941
    [Abstract] [Full Text] [Related]

  • 2. Impact of psychiatric comorbidity on the in-treatment outcomes of cocaine-dependent patients in therapeutic communities.
    González-Saiz F, Vergara-Moragues E, Verdejo-García A, Fernández-Calderón F, Lozano OM.
    Subst Abus; 2014; 35(2):133-40. PubMed ID: 24821349
    [Abstract] [Full Text] [Related]

  • 3. Psychiatric profile of three-month retention in cocaine-dependent patients treated in a therapeutic community.
    Vergara-Moragues E, González-Saiz F, Lozano OM, Verdejo García A.
    J Stud Alcohol Drugs; 2013 May; 74(3):452-9. PubMed ID: 23490575
    [Abstract] [Full Text] [Related]

  • 4. Psychiatric comorbidity in cocaine users treated in therapeutic community: substance-induced versus independent disorders.
    Vergara-Moragues E, González-Saiz F, Lozano OM, Betanzos Espinosa P, Fernández Calderón F, Bilbao-Acebos I, Pérez García M, Verdejo García A.
    Psychiatry Res; 2012 Dec 30; 200(2-3):734-41. PubMed ID: 22910475
    [Abstract] [Full Text] [Related]

  • 5. [Psychopathological comorbidity in cocaine users in outpatient treatment].
    Araos P, Vergara-Moragues E, Pedraz M, Pavón FJ, Campos Cloute R, Calado M, Ruiz JJ, García-Marchena N, Gornemann I, Torrens M, Rodríguez de Fonseca F.
    Adicciones; 2014 Dec 30; 26(1):15-26. PubMed ID: 24652395
    [Abstract] [Full Text] [Related]

  • 6. Psychopathological stability of personality disorders in substance abuse patients treated in a therapeutic community.
    Vergara-Moragues E, González-Saiz F, Lozano OM, Verdejo García A.
    J Addict Dis; 2013 Dec 30; 32(4):343-53. PubMed ID: 24325768
    [Abstract] [Full Text] [Related]

  • 7. Diagnosing adult attention deficit/hyperactivity disorder in patients with cocaine dependence: discriminant validity of Barkley executive dysfunction symptoms.
    Vergara-Moragues E, González-Saiz F, Lozano Rojas O, Bilbao Acedos I, Fernández Calderón F, Betanzos Espinosa P, Verdejo García A, Pérez García M.
    Eur Addict Res; 2011 Dec 30; 17(6):279-84. PubMed ID: 21912132
    [Abstract] [Full Text] [Related]

  • 8. Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community.
    Levin FR, Evans SM, Vosburg SK, Horton T, Brooks D, Ng J.
    Addict Behav; 2004 Dec 30; 29(9):1875-82. PubMed ID: 15530732
    [Abstract] [Full Text] [Related]

  • 9. Profiles of substance use disorders in patients of therapeutic communities: link to social, medical and psychiatric characteristics.
    Fernández-Calderón D, Fernández F, Ruiz-Curado S, Verdejo-García A, Lozano ÓM.
    Drug Alcohol Depend; 2015 Apr 01; 149():31-9. PubMed ID: 25682479
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A longitudinal analysis of factors associated with morbidity in cocaine abusers with psychiatric illness.
    Stanislav SW, Sommi RW, Watson WA.
    Pharmacotherapy; 1992 Apr 01; 12(2):114-8. PubMed ID: 1315023
    [Abstract] [Full Text] [Related]

  • 13. Differences in the Rates of Drug Polyconsumption and Psychiatric Comorbidity among Patients with Cocaine Use Disorders According to the Mental Health Service.
    Araos P, Vergara-Moragues E, González-Saiz F, Pedraz M, García-Marchena N, Romero-Sanchiz P, Ruiz JJ, Campos-Cloute R, Serrano A, Pavón FJ, Torrens M, Rodriguez De Fonseca F.
    J Psychoactive Drugs; 2017 Apr 01; 49(4):306-315. PubMed ID: 28682218
    [Abstract] [Full Text] [Related]

  • 14. Personality profile in young current regular users of cocaine.
    Herrero MJ, Domingo-Salvany A, Torrens M, Brugal MT, Gutiérrez F, Itinere Investigators.
    Subst Use Misuse; 2008 Apr 01; 43(10):1378-94. PubMed ID: 18696374
    [Abstract] [Full Text] [Related]

  • 15. Association between executive function and outcome measure of treatment in therapeutic community among cocaine dependent individuals.
    Vergara-Moragues E, Verdejo-García A, Lozano OM, Santiago-Ramajo S, González-Saiz F, Betanzos Espinosa P, Pérez García M.
    J Subst Abuse Treat; 2017 Jul 01; 78():48-55. PubMed ID: 28554603
    [Abstract] [Full Text] [Related]

  • 16. Psychiatric morbidity among cocaine and heroin users in the community.
    Tortajada S, Herrero MJ, Domingo-Salvany A, Molist G, Barrio G, de la Fuente L, Brugal MT, Grupo de Investigación ITINERE.
    Adicciones; 2012 Jul 01; 24(3):201-10. PubMed ID: 22868975
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of plasma-free endocannabinoids and their congeners in abstinent cocaine addicts seeking outpatient treatment: impact of psychiatric co-morbidity.
    Pavón FJ, Araos P, Pastor A, Calado M, Pedraz M, Campos-Cloute R, Ruiz JJ, Serrano A, Blanco E, Rivera P, Suárez J, Romero-Cuevas M, Pujadas M, Vergara-Moragues E, Gornemann I, Torrens M, de la Torre R, Rodríguez de Fonseca F.
    Addict Biol; 2013 Nov 01; 18(6):955-69. PubMed ID: 24283982
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.